<DOC>
	<DOC>NCT00621153</DOC>
	<brief_summary>To compare the changes in mean sitting DBP from baseline after 4 weeks of therapy with either candesartan cilexetil/HCT combination therapy or candesartan cilexetil monotherapy regimen</brief_summary>
	<brief_title>Candesartan Effect in Second Stage Arterial Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Stage II essential hypertension (SBP≥ 160 or DBP≥100 mmHg), untreated, or treated with a maximum of 2 class of antihypertensive drugs Current serumcreatinine &gt;3 mg/dL, Current serumpotassium &gt;5.5 mmol/L, 16. Pregnant or lactating women or women of childbearing potential who were not protected from pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Candesartan Cilexetil</keyword>
	<keyword>hydrochlorothiazide</keyword>
	<keyword>severe hypertension</keyword>
</DOC>